HCA Holdings Inc. buy Royal Bank of Canada
Start price
29.04.24
/
50%
€290.50
Target price
29.04.25
€307.19
Performance (%)
7.41%
Price
09:30
€311.40
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.41%. Dividends of €0.62 are taken into consideration when calculating the performance. This prediction currently runs until 29.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
HCA Holdings Inc. | 6.972% | 6.972% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) had its price target raised by analysts at Royal Bank of Canada from $322.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for HCA provided by MarketBeat